The US Food and Drug Administration (FDA) has granted 510(k) clearance for MicroPort Navibot’s robot-assisted SkyWalker System for orthopaedic applications.

The new platform is said to be compatible with the Evolution Medial-Pivot Total Knee System and will initially be used in total knee replacements.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The SkyWalker System helps surgeons formulate a personalised patient implant plan from preoperative CT scan anatomical data and specific implant data before the actual surgery.

It has the technical advantages of providing accurate operation and efficient coordination.

The new robot-assisted platform enables precise implant positioning that depends on actual patient alignment and anatomy during the surgery

It then allows the surgeon to proceed to resectioning using a lightweight mechanical arm, resulting in improved accuracy, precision and efficiency.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The device can provide information that helps achieve the desired joint line reconstruction and also delivers data to optimally balance soft tissues.

In the future, MicroPort Navibot plans to develop other orthopaedic applications with MicroPort Orthopedics to offer more comprehensive orthopaedic solutions.

The company has constructed a full technology research facility, which is designed based on clinical needs.

With medical industry design capabilities, the facility is said to benefit from core technological advantages and a high-dexterity, lightweight, self-developed mechanical arm combined with intelligent planning and navigation algorithms.

In January, MicroPort Scientific’s subsidiary MicroPort CRM received Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approval for Alizea, the company’s latest range of pacemakers.

The implantable pacemakers are paired with the company’s SmartView Connect home monitor.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact